INDOCO REMEDIES
|
The Current P/E Ratio of INDOCO REMEDIES is 645.21.
| Share Price | ₹216.7 | Aug 12,2026 |
| Market Cap | ₹2,000.1 Cr | |
| Earnings-TTM | ₹3.1 Cr | TTM-Consolidated Results |
| Price/Earnings | 645.21x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of INDOCO REMEDIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,000.1 Cr] as on Aug 12,2026
(/) Earnings [ ₹3.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 645.21x ]
Thus, for INDOCO REMEDIES , the investors are currently willing to pay 645.21 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of INDOCO REMEDIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of INDOCO REMEDIES over the last five years.
Historical PE (Price/Earnings) ratio chart of INDOCO REMEDIES
PE Ratio Performance Analysis for INDOCO REMEDIES
- INDOCO REMEDIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 20.57x.
- INDOCO REMEDIES 's operated at median p/e ratio of 22.42x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDOCO REMEDIES 's p/e ratio peaked in Mar2024 at 30.76x.
- INDOCO REMEDIES 's p/e ratio hit its five-year low in Mar2025 of 0x.
How does INDOCO REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| INDOCO REMEDIES | 3.10 | 645.21 | 2,000.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 38.14 | 464,271.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 77.55 | 226,843.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 86.27 | 186,000.0 |
| CIPLA LTD | 3,364.84 | 35.09 | 118,072.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 31.58 | 100,073.0 |
| MANKIND PHARMA LTD | 2,055.11 | 48.73 | 100,137.0 |
| LUPIN LTD | 5,551.01 | 18.65 | 103,550.0 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 26.74 | 120,099.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.80 | 95,797.5 |
| LAURUS LABS LTD | 1,090.76 | 91.20 | 99,474.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs INDOCO REMEDIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.65x |
| Max industry PE | 645.21x |
| Median industry PE | 38.14x |
| Average industry PE | 102.27x |
You may also like the below Video Courses